• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病微血管并发症是脆性骨折的危险因素吗?

Are diabetes microvascular complications risk factors for fragility fracture?

作者信息

Almutlaq Nourah, Neyman Anna, DiMeglio Linda A

机构信息

Division of Pediatric Endocrinology and Diabetology.

Wells Center for Pediatric Research, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):354-359. doi: 10.1097/MED.0000000000000642.

DOI:10.1097/MED.0000000000000642
PMID:33989258
Abstract

PURPOSE OF REVIEW

We describe relationships between microvascular complications and bone fragility fracture in the context of diabetes. We highlight gaps in knowledge and suggest areas of further study.

RECENT FINDINGS

Evidence in type 1 diabetes (T1D) demonstrates that low bone mineral density (BMD) is associated with microvascular complications and linked to increased fracture risk. Of note, the low BMD does not solely explain bone fragility. Microvascular disease also has been linked to compromised bone microarchitecture and poorer bone quality. Moreover, microvascular complications may indirectly increase the rate of fragility fracture through increasing fall propensity; however, to date no conclusive studies have assessed microvascular disease and fracture risk independent of falls.In the other hand, individuals with type 2 diabetes (T2D) have increased fracture risk despite high BMD. Data suggest microvascular disease mediates microarchitectural changes by increasing cortical porosity and is associated with lower bone turnover. There is no direct evidence linking microangiopathy to fracture incidence.

SUMMARY

Taken together present evidence suggests associations between diabetic bone disease, fragility fracture, and microvascular disease. Data are more convincing for T1D than T2D. Further studies are required to confirm whether microvascular disease is itself causative of fracture or merely a contributory factor to fragility fracture for persons with diabetes.

摘要

综述目的

我们描述了糖尿病背景下微血管并发症与骨脆性骨折之间的关系。我们强调了知识空白并提出了进一步研究的领域。

最新发现

1型糖尿病(T1D)的证据表明,低骨矿物质密度(BMD)与微血管并发症相关,并与骨折风险增加有关。值得注意的是,低骨密度并不能完全解释骨脆性。微血管疾病还与骨微结构受损和较差的骨质量有关。此外,微血管并发症可能通过增加跌倒倾向间接增加脆性骨折的发生率;然而,迄今为止,尚无确凿研究评估独立于跌倒因素的微血管疾病与骨折风险之间的关系。另一方面,2型糖尿病(T2D)患者尽管骨密度高,但骨折风险增加。数据表明,微血管疾病通过增加皮质骨孔隙率介导骨微结构变化,并与较低的骨转换率相关。没有直接证据表明微血管病变与骨折发生率有关。

总结

综合现有证据表明,糖尿病性骨病、脆性骨折和微血管疾病之间存在关联。对于T1D的数据比T2D更有说服力。需要进一步研究以确认微血管疾病本身是否是骨折的病因,还是仅仅是糖尿病患者脆性骨折的一个促成因素。

相似文献

1
Are diabetes microvascular complications risk factors for fragility fracture?糖尿病微血管并发症是脆性骨折的危险因素吗?
Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):354-359. doi: 10.1097/MED.0000000000000642.
2
Skeletal Fragility in Adult People Living With Type 1 Diabetes.成年人 1 型糖尿病患者的骨骼脆弱性。
Endocr Pract. 2024 Jun;30(6):592-597. doi: 10.1016/j.eprac.2024.03.392. Epub 2024 Mar 29.
3
Osteoporosis and risk of fracture in patients with diabetes: an update.骨质疏松症和糖尿病患者骨折风险:更新。
Aging Clin Exp Res. 2011 Apr;23(2):84-90. doi: 10.1007/BF03351073.
4
The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus.2 型糖尿病患者肌少症、跌倒和骨折的风险。
Maturitas. 2018 Mar;109:70-77. doi: 10.1016/j.maturitas.2017.12.011. Epub 2017 Dec 15.
5
Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.对糖尿病患者骨脆性的见解:骨质量对骨骼强度的关键作用。
Endocr J. 2015;62(4):299-308. doi: 10.1507/endocrj.EJ15-0129. Epub 2015 Mar 21.
6
The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study.1 型和 2 型糖尿病女性的糖尿病-骨折关联部分通过跌倒介导:一项 15 年的纵向研究。
Osteoporos Int. 2021 Jun;32(6):1175-1184. doi: 10.1007/s00198-020-05771-9. Epub 2021 Jan 7.
7
Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.1型和2型糖尿病中的骨骼代谢、骨折风险及骨折结局
Diabetes. 2016 Jul;65(7):1757-66. doi: 10.2337/db16-0063.
8
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.2 型糖尿病患者的脆性骨管理:跨学科专家小组的观点。
Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2210-2233. doi: 10.1016/j.numecd.2021.04.014. Epub 2021 Apr 28.
9
Bone health in type 1 diabetes.1 型糖尿病患者的骨骼健康。
Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):231-236. doi: 10.1097/MED.0000000000000421.
10
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.1型和2型糖尿病患者骨矿物质密度与骨折风险的差异——一项荟萃分析
Osteoporos Int. 2007 Apr;18(4):427-44. doi: 10.1007/s00198-006-0253-4. Epub 2006 Oct 27.

引用本文的文献

1
Prevalence of osteoporosis in chronic diseases: an umbrella review of 283 observational studies from 13 systematic reviews.慢性病中骨质疏松症的患病率:来自13项系统评价的283项观察性研究的综合评价
BMC Rheumatol. 2025 Jun 6;9(1):66. doi: 10.1186/s41927-025-00520-z.
2
Diosmin Administration Slightly Counteracted the Changes in Bone Mechanical Properties Induced by Experimental Type 1 Diabetes in Rats.地奥司明给药略微抵消了实验性1型糖尿病诱导的大鼠骨力学性能变化。
Pharmaceuticals (Basel). 2025 May 13;18(5):715. doi: 10.3390/ph18050715.
3
Fracture risk assessment in diabetes mellitus.
糖尿病患者的骨折风险评估。
Front Endocrinol (Lausanne). 2022 Sep 2;13:961761. doi: 10.3389/fendo.2022.961761. eCollection 2022.
4
IL-6 and Leptin Are Potential Biomarkers for Osteoporotic Fracture Risk Assessment and Prediction of Postmenopausal Women with Low Bone Mass: A Follow-Up Study Using a Regional Sample Cohort.IL-6 和瘦素是骨质疏松性骨折风险评估和低骨量绝经后妇女预测的潜在生物标志物:使用区域样本队列的随访研究。
Oxid Med Cell Longev. 2022 Aug 10;2022:8691830. doi: 10.1155/2022/8691830. eCollection 2022.
5
The interplay between diabetes mellitus and menopause: clinical implications.糖尿病与绝经的相互作用:临床意义。
Nat Rev Endocrinol. 2022 Oct;18(10):608-622. doi: 10.1038/s41574-022-00708-0. Epub 2022 Jul 7.